Data / Form D filings / Knopp Neurosciences Inc.
Knopp Neurosciences Inc.: Form D filings
Knopp Neurosciences Inc., a biotechnology company in Pittsburgh, PA, filed 4 Form D notices with the SEC between 2009 and 2010. The latest, on September 3, 2010, reports $60 million sold of a $60 million offering to 1 investor.
Find out what Knopp Neurosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2100 WHARTON STREET, SUITE 615, Pittsburgh, PA, 15203
- Phone
- (412) 488-1776
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1347819
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 3, 2010 | New notice | $60,000,000 | $60,000,000 | $0 | 1 | Aug 23, 2010 | sec.gov |
| Jan 13, 2010 | Amendment | $12,500,001 | $8,500,001 | $4,000,000 | 26 | Sep 21, 2009 | sec.gov |
| Dec 23, 2009 | Amendment | $12,500,001 | $4,423,875 | $8,076,126 | 26 | Sep 21, 2009 | sec.gov |
| Sep 23, 2009 | New notice | $12,500,001 | $23,257 | $12,476,744 | 2 | Sep 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Valentin K. Gribkoff | Executive Officer | |
| Thomas W. Petzinger, Jr. | Director, Executive Officer, Promoter | |
| Gregory T. Hebrank | Director, Executive Officer, Promoter | |
| Michael E. Bozik | Director, Executive Officer, Promoter | |
| Jeffrey S. McCormick | Director | |
| Benjamin A. Gomez | Director | |
| Evan W. Ingersoll | Executive Officer |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Aug 30, 2010 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Knopp Neurosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.